10 Apr 2019

Teleflex gets premarket OK for biomechanical MANTA Closure

  Teleflex Inc., a global provider of medical technologies for critical care and surgery, has announced that it received premarket approval from the U.S. Food and Drug Administration for the MANTA Vascular Closure Device – the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial

0
28 Mar 2019

A NEW RF SYSTEM: VENCLOSE 2ND GENERATION RADIOFREQUENCY TECHNOLOGY OUTPERFORMS LEGACY SYSTEM

    By Larry Storer The great medical technology companies of our time start and develop in a variety of ways. Some start with a product or idea and built a market around it. Some start as spinoffs from existing successful companies. But Venclose started by determining the unmet needs

0
28 Mar 2019

FDA evaluating stents, balloons with paclitaxel coating following JAHA evaluation

A December study in The Journal of the American Heart Association by Konstantinos Katsanos, MD, of Rion, Greece, et al, reported a higher risk of death after balloons and stents used to open vessels in the legs were coated with an anti-inflammatory chemo agent called paclitaxel. “Further investigations are urgently

0
15 Mar 2019

AVLS HOSTS Virtual Reality-BASED COURSE ON SCLEROTHERAPY

The American Vein & Lymphatic Society is offering a full day course on sclerotherapy featuring its new virtual reality hands-on training. The sclerotherapy course will be offered at 8 a.m. April 6 at the Sheraton Suites Chicago O’Hare in Rosemont, Illinois.             Register at phleboloy.org.

0
14 Mar 2019

 AMERICAN VEIN & VASCULAR INSTITUTE IS CELEBRATING ITS 10-YEAR ANNIVERSARY

    American Vein & Vascular Institute is now celebrating its 10-year anniversary with special events at each of the seven clinics located throughout Colorado. Patient specials and community engagements invite patients and regional residents alike to join in on American Vein’s success and hard-earned longevity. American Vein & Vascular

0
13 Mar 2019

HOW MUCH DIFFERENCE WILL ELI LILLY’S HALF-PRICE INSULIN MAKE?

  By Bram Sable-Smith When Erin Gilmer filled her insulin prescription at a Denver-area Walgreens in January, she paid $8.50. U.S. taxpayers paid another $280.51. “It eats at me to know that taxpayer money is being wasted,” said Gilmer, who has Medicare and was diagnosed with Type 1 diabetes while

0
07 Mar 2019

FDA COMMISSIONER SCOTT GOTTLIEB RESIGNS

U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, resigned March 5, but will remain in his position until April 5. Dr. Gottlieb, who has led the FDA since May 2017, did not offer a reason for his departure in his resignation letter, although he included: “We were strong

0
19 Jan 2019

ELECTRONICS INDUSTRY WANTS A SLICE OF THE HEALTHCARE REVENUE PIE

By Eric Taub If the scores of personal health care devices at the Consumer Electronics Show in January are any indication, it’s clear that the Apple Watch has kicked off a rush by high-tech companies to capitalize on people’s worries about their health. The latest version of the watch, which was

0
09 Jan 2019

ENDOLOGIX RECALLS NELLIX SYSTEM FOR PATIENT SAFETY

Endologix Inc., a developer and marketer of treatments for aortic disorders, has stopped unrestricted sales and use of the Nellix System in order to ensure optimal outcomes for patients. The existing inventory will be voluntarily recalled as described in a Field Safety Notification (FSN) issued in January. The Nellix System

0
08 Jan 2019

INTERVENTIONAL RADIOLOGY SOCIETIES CALL FOR EXPANDED STROKE TRAINING

The Society of Interventional Radiology (SIR), the Cardiovascular and Interventional Radiology Society of Europe and the Interventional Radiology Society of Australasia have formed a Joint Commission committed to providing necessary stroke training to interventional radiologists in order to alleviate the shortage of physicians trained in endovascular stroke therapies. The ability for patients

0